Cargando…

Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats

INTRODUCTION: Adipose derived mesenchymal stem cells (ADMSCs), carrying the similar characteristics to bone marrow mesenchymal stem cells, only much more abundant and easier to obtain, may be a promising treatment for liver fibrosis. We aim to investigate the therapeutic potential of ADMSCs transpla...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Lian, Fan, Li, Jiaping, Fan, Wenzhe, Xu, Hanshi, Yang, Xiuyan, Liang, Liuqin, Chen, Wei, Yang, Jianyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439354/
https://www.ncbi.nlm.nih.gov/pubmed/22735033
http://dx.doi.org/10.1186/1479-5876-10-133
_version_ 1782242988372525056
author Wang, Yu
Lian, Fan
Li, Jiaping
Fan, Wenzhe
Xu, Hanshi
Yang, Xiuyan
Liang, Liuqin
Chen, Wei
Yang, Jianyong
author_facet Wang, Yu
Lian, Fan
Li, Jiaping
Fan, Wenzhe
Xu, Hanshi
Yang, Xiuyan
Liang, Liuqin
Chen, Wei
Yang, Jianyong
author_sort Wang, Yu
collection PubMed
description INTRODUCTION: Adipose derived mesenchymal stem cells (ADMSCs), carrying the similar characteristics to bone marrow mesenchymal stem cells, only much more abundant and easier to obtain, may be a promising treatment for liver fibrosis. We aim to investigate the therapeutic potential of ADMSCs transplantation in liver fibrosis caused by carbon tetrachloride (CCl(4)) in rats as well as its underlying mechanism, and to further explore the appropriate infusion pathway. METHODS: ADMSCs were isolated, cultured and identified. Placebo and ADMSCs were transplanted via portal vein and tail vein respectively into carbon tetrachloride (CCl(4))-induced liver fibrosis rats. Computed tomography (CT) perfusion scan and microvessel counts were performed to measure the alteration of liver microcirculation after therapy. Liver function tests and histological findings were estimated. RESULTS: CT perfusion scan shown significant decrease of hepatic arterial perfusion index, significant increased portal vein perfusion, total liver perfusion in rats receiving ADMSCs from portal vein, and Factor VIII (FVIII) immunohistochemical staining shown significant decrease of microvessels in rats receiving ADMSCs from portal vein, indicating microcirculation improvement in portal vein group. Vascular endothelial growth Factor (VEGF) was significantly up-regulated in fibrosis models, and decreased after ADMSCs intraportal transplantation. A significant improvement of liver functional test and histological findings in portal vein group were observed. No significance was found in rats receiving ADMSCs from tail vein. CONCLUSIONS: ADMSCs have a therapeutic effect against CCl(4)-mediated liver fibrosis. ADMSCs may benefit the fibrotic liver through alteration of microcirculation, evidenced by CT perfusion scan and down-regulation of VEGF. Intraportal transplantation is a better pathway than tail vein transplantation.
format Online
Article
Text
id pubmed-3439354
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34393542012-09-12 Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats Wang, Yu Lian, Fan Li, Jiaping Fan, Wenzhe Xu, Hanshi Yang, Xiuyan Liang, Liuqin Chen, Wei Yang, Jianyong J Transl Med Research INTRODUCTION: Adipose derived mesenchymal stem cells (ADMSCs), carrying the similar characteristics to bone marrow mesenchymal stem cells, only much more abundant and easier to obtain, may be a promising treatment for liver fibrosis. We aim to investigate the therapeutic potential of ADMSCs transplantation in liver fibrosis caused by carbon tetrachloride (CCl(4)) in rats as well as its underlying mechanism, and to further explore the appropriate infusion pathway. METHODS: ADMSCs were isolated, cultured and identified. Placebo and ADMSCs were transplanted via portal vein and tail vein respectively into carbon tetrachloride (CCl(4))-induced liver fibrosis rats. Computed tomography (CT) perfusion scan and microvessel counts were performed to measure the alteration of liver microcirculation after therapy. Liver function tests and histological findings were estimated. RESULTS: CT perfusion scan shown significant decrease of hepatic arterial perfusion index, significant increased portal vein perfusion, total liver perfusion in rats receiving ADMSCs from portal vein, and Factor VIII (FVIII) immunohistochemical staining shown significant decrease of microvessels in rats receiving ADMSCs from portal vein, indicating microcirculation improvement in portal vein group. Vascular endothelial growth Factor (VEGF) was significantly up-regulated in fibrosis models, and decreased after ADMSCs intraportal transplantation. A significant improvement of liver functional test and histological findings in portal vein group were observed. No significance was found in rats receiving ADMSCs from tail vein. CONCLUSIONS: ADMSCs have a therapeutic effect against CCl(4)-mediated liver fibrosis. ADMSCs may benefit the fibrotic liver through alteration of microcirculation, evidenced by CT perfusion scan and down-regulation of VEGF. Intraportal transplantation is a better pathway than tail vein transplantation. BioMed Central 2012-06-26 /pmc/articles/PMC3439354/ /pubmed/22735033 http://dx.doi.org/10.1186/1479-5876-10-133 Text en Copyright ©2012 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wang, Yu
Lian, Fan
Li, Jiaping
Fan, Wenzhe
Xu, Hanshi
Yang, Xiuyan
Liang, Liuqin
Chen, Wei
Yang, Jianyong
Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats
title Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats
title_full Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats
title_fullStr Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats
title_full_unstemmed Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats
title_short Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats
title_sort adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by ccl4 in rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439354/
https://www.ncbi.nlm.nih.gov/pubmed/22735033
http://dx.doi.org/10.1186/1479-5876-10-133
work_keys_str_mv AT wangyu adiposederivedmesenchymalstemcellstransplantationviaportalveinimprovesmicrocirculationandamelioratesliverfibrosisinducedbyccl4inrats
AT lianfan adiposederivedmesenchymalstemcellstransplantationviaportalveinimprovesmicrocirculationandamelioratesliverfibrosisinducedbyccl4inrats
AT lijiaping adiposederivedmesenchymalstemcellstransplantationviaportalveinimprovesmicrocirculationandamelioratesliverfibrosisinducedbyccl4inrats
AT fanwenzhe adiposederivedmesenchymalstemcellstransplantationviaportalveinimprovesmicrocirculationandamelioratesliverfibrosisinducedbyccl4inrats
AT xuhanshi adiposederivedmesenchymalstemcellstransplantationviaportalveinimprovesmicrocirculationandamelioratesliverfibrosisinducedbyccl4inrats
AT yangxiuyan adiposederivedmesenchymalstemcellstransplantationviaportalveinimprovesmicrocirculationandamelioratesliverfibrosisinducedbyccl4inrats
AT liangliuqin adiposederivedmesenchymalstemcellstransplantationviaportalveinimprovesmicrocirculationandamelioratesliverfibrosisinducedbyccl4inrats
AT chenwei adiposederivedmesenchymalstemcellstransplantationviaportalveinimprovesmicrocirculationandamelioratesliverfibrosisinducedbyccl4inrats
AT yangjianyong adiposederivedmesenchymalstemcellstransplantationviaportalveinimprovesmicrocirculationandamelioratesliverfibrosisinducedbyccl4inrats